No Data
No Data
Guardant Health (NASDAQ:GH Shareholders Incur Further Losses as Stock Declines 8.9% This Week, Taking Three-year Losses to 68%
Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care
Express News | Cota and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development With Real-World Clinicogenomic Data and AI Analytics
COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development With Real-World Clinicogenomic Data and AI Analytics
Express News | Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer
Express News | Guardant Health Inc : Guggenheim Raises Target Price to $40 From $36